Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2019
The Apparent Genetic Anticipation in PMS2-Associated Lynch Syndrome Families Is Explained by Birth-cohort EffectSanne W Ten Broeke, Mar Rodríguez-Girondo, Manon Suerink, et al.Familial Cancer|November 18, 2017
SNP association study in PMS2-associated Lynch syndromeSanne W Ten Broeke, Fadwa A Elsayed, Lisa Pagan, et al.Human Mutation|February 27, 2010
Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of Lynch syndrome patientsHeleen M van der Klift, Carli M J Tops, Elsa C Bik, et al.Human Mutation|March 10, 2011
Deciphering the colon cancer genes--report of the InSiGHT-Human Variome Project Workshop, UNESCO, Paris 2010Maija R J Kohonen-Corish, Finlay Macrae, Maurizio Genuardi, et al.Human Mutation|July 21, 2016
Comprehensive Mutation Analysis of PMS2 in a Large Cohort of Probands Suspected of Lynch Syndrome or Constitutional Mismatch Repair Deficiency SyndromeHeleen M van der Klift, Arjen R Mensenkamp, Mark Drost, et al.Human Mutation|August 21, 2010
Leiden Open Variation Database of the MUTYH geneAstrid A Out, Carli M J Tops, Maartje Nielsen, et al.Human Mutation|February 11, 2011
Recurrence and variability of germline EPCAM deletions in Lynch syndromeRoland P Kuiper, Lisenka E L M Vissers, Ramprasath Venkatachalam, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2018
Cancer Risks for PMS2-Associated Lynch SyndromeSanne W Ten Broeke, Heleen M van der Klift, Carli M J Tops, et al.The Lancet. Oncology|December 15, 2010
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort studyMarlies J E Kempers, Roland P Kuiper, Charlotte W Ockeloen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2012
MAX mutations cause hereditary and sporadic pheochromocytoma and paragangliomaNelly Burnichon, Alberto Cascón, Francesca Schiavi, et al.Pageof 4